Technology
Health
Biotechnology

BioXcel Therapeutics

596

$5.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.74 (+16.95%) As of 3:55 PM EST today
+$0.74 (+16.95%) Today

Why Robinhood?

You can buy or sell BTAI and other stocks, options, ETFs, and crypto commission-free!

About BTAI

BioXcel Therapeutics, Inc. Common Stock, also called BioXcel Therapeutics, is a clinical stage biopharmaceutical company focuses on drug development. Read More The firm's two clinical development programs are BXCL501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.

CEO
Vimal D. Mehta
Employees
18
Headquarters
New Haven, Connecticut
Founded
2017
Market Cap
78.63M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
79.10K
High Today
$5.24
Low Today
$4.48
Open Price
$4.79
Volume
133.32K
52 Week High
$12.00
52 Week Low
$2.41

Collections

Technology
Health
Biotechnology
Medical
Therapy
Biopharmaceutical
Cancer Prevention
Pharmaceutical

BTAI Earnings

-$0.65
-$0.50
-$0.34
-$0.19
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
-$0.65 per share
Actual
-$0.57 per share
Replay Earnings Call

You May Also Like

TESS
DXGE
DRQ
TGI
CIK
MRVL
IEC
MMX
LAND
SHAK
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy BTAI

Market Price$5.10
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell BTAI stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up